Unknown

Dataset Information

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials.


ABSTRACT:

Background

Safe, more efficacious treatments are needed to address the considerable morbidity and mortality associated with pulmonary tuberculosis (TB). However, the current practice in TB therapeutics trials is to use composite binary outcomes, which in the absence of standardization may inflate false positive and negative errors in evaluating regimens. The lack of standardization of outcomes is a barrier to the identification of highly efficacious regimens and the introduction of innovative methodologies METHODS: We conducted a systematic review of trials designed to advance new pulmonary TB drugs or regimens for regulatory approval and inform practice guidelines. Trials were primarily identified from the WHO International Clinical Trial Registry Platform (ICTRP). Only trials tha

SUBMITTER: Hills NK 

PROVIDER: S-EPMC8329622 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature